Health

Continuous glycemic monitoring uses only basal insulin to improve outcomes in people with type 2 diabetes

Continuous blood glucose monitoring significantly reduced hgA1C levels in poorly controlled type 2 diabetic patients compared to glucose meter monitoring, according to a study published in. JAMA. The benefits of continuous glucose monitoring for diabetics have been previously demonstrated, but researchers have found that these benefits are for patients with type 1 diabetes or for patients with type 2 diabetes treated with multiple daily insulin injections. He said it was well established only for. However, current studies demonstrate the benefits of continuous glucose monitoring in patients with type 2 diabetes treated solely with basal insulin, a long-acting insulin designed to be injected once or twice daily. This is one of the first studies I did.

“This trial not only demonstrates the benefits of continuous glucose monitoring for these patients, a technology not covered by many insurers of type 2 diabetes, but these benefits are broad socio-economic status. Rodica Busui, MD, PhD, Vice-Chair of Clinical Research, Department of Internal Medicine, University of Michigan, said in a press release.

A total of 175 patients were enrolled in this study, of which about half belonged to racial or ethnic minorities. Each participant received one or two daily injections of long-acting basal insulin, with or without non-insulin drugs, to help lower blood sugar levels. In addition to testing the effectiveness of continuous glycemic monitoring in combination with basal insulin, researchers have shown how the impact of this diabetes treatment approach affects patients’ compliance with disease management and overall life satisfaction. I intended to study.

On average, hgA1C decreased by 1.1% in patients using continuous glucose monitoring to manage diabetes, compared to 0.16% in patients using glucose meter monitoring. In addition, all 175 participants had improved compliance with diabetes management and increased life satisfaction.

“The most exciting thing for me is that this study shows the blood glucose levels of patients whose use of continuous blood glucose monitoring was randomized to use a continuous blood glucose monitor compared to regular finger stabs. It’s showing that it’s significantly improved and effective in reducing the risk of hypoglycemia, “Busui said in the release. “This could give all diabetics a wide range of coverage of this breakthrough technology. They have access to this resource and are educated by primary care physicians about the benefits of patients using it. With it, more patients can manage their diabetes. “

reference

No need to stab your finger: Continuous blood glucose monitoring benefits diabetics in one or more ways [news release].. ScienceDaily; July 26, 2021. Accessed on July 29, 2021. https://www.sciencedaily.com/releases/2021/07/210726170357.htm

ExBulletin

Continuous glycemic monitoring uses only basal insulin to improve outcomes in people with type 2 diabetes